| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 06/27/2002 | WO2002049428A1 Preservation of cells |
| 06/27/2002 | WO2002029016A3 Thermostable polymerase based on thermococcus pacificus |
| 06/27/2002 | WO2002024917A3 Method for modifying the genome of corynebacteria |
| 06/27/2002 | WO2002016548A3 Novel g protein-coupled receptor |
| 06/27/2002 | WO2002016433A3 Two receptors of meiosis activating sterols designated sam1a and sam1b |
| 06/27/2002 | WO2002016415A3 Identification of a cam-kinase ii inhibitor |
| 06/27/2002 | WO2002012543A3 Two coloured fluorimetric protease assay |
| 06/27/2002 | WO2002012291A3 Novel nucleotide sequences coding for the luxr gene and a process for the production of l-amino acids |
| 06/27/2002 | WO2001083746A3 Regulatory nucleic acid sequences of the abc1 gene |
| 06/27/2002 | WO2001079450A3 Streptomyces galbus strain with insecticidal activity and method of using as an insecticide |
| 06/27/2002 | WO2001073025A3 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains |
| 06/27/2002 | WO2001072994A3 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising the same, and methods of use thereof |
| 06/27/2002 | WO2001070987A3 Novel inflorescence meristem development gene, promoter, and methods of use for same |
| 06/27/2002 | WO2001070978A3 Polypeptides and nucleic acids encoding same |
| 06/27/2002 | WO2001061020A3 Alteration of growth and adaptation under hypoxic conditions |
| 06/27/2002 | WO2001044816B1 Conformational and topological protein regulation |
| 06/27/2002 | WO2001038358A9 Hbv/hcv virus-like particle |
| 06/27/2002 | WO2001014536A3 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 06/27/2002 | WO2000071561A9 Cd4-independent hiv envelope proteins as vaccines and therapeutics |
| 06/27/2002 | WO2000061819A9 Methods of detection and modulation of age-related mutations |
| 06/27/2002 | US20020083494 Genes regulating circadian clock function and photoperiodism |
| 06/27/2002 | US20020083492 Basidiomycete peroxidase gene-transferred plant and a method for decomposing and removing hazardous chemicals using the same |
| 06/27/2002 | US20020083489 DNA molecules and polypeptides of pseudomonas syringae Hrp pathogenicity island and their uses |
| 06/27/2002 | US20020083488 Mutating nucleotide sequences; obtain nucleotide sequence, incubate with mutant primers and polymerase, amplify nucleotide sequence, digest recover product, screen for primer sequences |
| 06/27/2002 | US20020083486 Chimeric plant promoters and plants containing the same |
| 06/27/2002 | US20020082413 PGC-1, a novel brown fat PPARgamma coactivator |
| 06/27/2002 | US20020082410 Insulin promoter factor, and uses related thereto |
| 06/27/2002 | US20020082388 Polypeptide for use in the treatment, diagnosis and prevention of cancer, nervous system and developmental disorders |
| 06/27/2002 | US20020082234 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 06/27/2002 | US20020082231 Utilizing ratC polypeptides to screen for antibacterial compounds |
| 06/27/2002 | US20020082211 Human presenilin variant |
| 06/27/2002 | US20020082205 Human FGF-23 gene and gene expression products |
| 06/27/2002 | US20020082191 Amino acid sequences of the transport proteins encoded by genes within the human genome; isolated peptide and nucleic acid molecules, methods of identifying orthologs, paralogs and modulators of the kinase peptides; brain disorders |
| 06/27/2002 | US20020082190 Amino acid sequences of the transport proteins encoded by genes within the human genome; isolated peptide and nucleic acid molecules, methods of identifying orthologs, paralogs and modulators of the kinase peptides; brain disorders |
| 06/27/2002 | US20020081737 Generating biocompatible bead; obtain bead, incubate with probes, immobilize probe to bead, recover bead |
| 06/27/2002 | US20020081731 Controlling metabolite generation in plants; generate plant culture, incubate with methylation inhibitor, culture cells, maintain cells |
| 06/27/2002 | US20020081720 Receptor activator of NF-kappaB |
| 06/27/2002 | US20020081718 Polypeptide, and a dna sequence to which a protein containing the polypetide binds |
| 06/27/2002 | US20020081712 Intensifying propagation of lactic acid bacteria; obtain lactic acid bacteria, incubate with lactic acid bacteria defective in pyruvate metabolism, propagate, recover bacteria |
| 06/27/2002 | US20020081703 Reducing allegenic response heterologous proteins; obtain nucleotide sequences of heterologous protein, insert subtilisin sequences, transform cell, expression vector, recover protein, monitor human to protein |
| 06/27/2002 | US20020081695 Nucleotide sequences coding polypeptide for use in the treatment of blood disorders, gout, kidney stones, Lesch-Nyhan syndrome, renal failure and uricaciduria |
| 06/27/2002 | US20020081690 Hybrid enzyme and use thereof |
| 06/27/2002 | US20020081686 Novel antimicrobial therapies |
| 06/27/2002 | US20020081682 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of bacterial infections |
| 06/27/2002 | US20020081681 Nucleotide sequences coding enzymatic polypeptides for use in the treatment of kidney disorders |
| 06/27/2002 | US20020081676 Method for producing an oxide with a fermentation process |
| 06/27/2002 | US20020081674 Nucleotide sequences coding enzymatic polypeptide for generation of lysine and valine for use in human medicine and animal nutrients |
| 06/27/2002 | US20020081673 Polynucleotide sequences which code enzymatic polypeptide for use in generation of lysine for human medicines and animal nutrients |
| 06/27/2002 | US20020081665 Composition for use as immunomodulatory and anticarcinogenic agents |
| 06/27/2002 | US20020081659 Nucleic acids, proteins and antibodies |
| 06/27/2002 | US20020081656 UDP-N-acetylglucosamine: Galactose-beta1,3-N-acetylgalactosamine-alpha-R / N-acetylglucosamine-beta1,3,-N-acetylgalactosamine-alpha-R (GlcNAc to GalNAc) beta1,6-N-acetylglucosaminyltransferase, C2/4GnT |
| 06/27/2002 | US20020081653 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/27/2002 | US20020081649 Peptide for use in human therapeutics and diagnostics; for use as a antitumor agent |
| 06/27/2002 | US20020081648 Peptide for use in human thereapeutics and diagnostics |
| 06/27/2002 | US20020081646 Production method of polyhydroxyalkanoate form substituted fatty acid ester as raw material |
| 06/27/2002 | US20020081642 Serodiagnostic test; for use in the detection of microorganisms in sample |
| 06/27/2002 | US20020081607 Four disulfide core domain-containing (FDCD) polynucleotides, polypeptides, and antibodies |
| 06/27/2002 | US20020081605 Method for detecting growth hormone variations in humans, the variations and their uses |
| 06/27/2002 | US20020081584 Nucleotide sequences coding preferential polypeptide for use in the diagnosis, prevention and treatment of schizophrenia |
| 06/27/2002 | US20020081581 Compositions and methods for reverse transcription of nucleic acid molecules |
| 06/27/2002 | US20020081578 Nucleotide sequences coding preferential polypeptide for as anticarcinogenic agents |
| 06/27/2002 | US20020081568 Hepatitis C virus NS5B truncated protein and methods thereof to identify antiviral compounds |
| 06/27/2002 | US20020081565 Process for producing freeze dried competent cells and use thereof in cloning |
| 06/27/2002 | US20020081357 Process for producing yeast extracts |
| 06/27/2002 | US20020081317 Bacteria rendered non-pathogenic having altered DNA adenine methylase activity, genetically engineered to express a heterologous antigen such as immunogenic antigen of a virus, protozoa, parasite or fungi |
| 06/27/2002 | US20020081296 Methods and compositions of matter concerning APRIL/G70, BCMA, BLYS/AGP-3 and TACI |
| 06/27/2002 | US20020081290 Protein kinase homologs |
| 06/27/2002 | US20020081286 NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 06/27/2002 | US20020079268 First nanofiltration and/or electrodialysis to eliminate low molecular weight impurities without degrading its concentration of carbon sources; high purity metabolites such as L-lactic acid |
| 06/27/2002 | CA2789252A1 Streptococcus pyogenes antigens and corresponding dna fragments |
| 06/27/2002 | CA2714357A1 Mutations in neuronal gene sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 06/27/2002 | CA2433308A1 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r4 |
| 06/27/2002 | CA2433027A1 Nucleic acid-associated proteins |
| 06/27/2002 | CA2432762A1 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 06/27/2002 | CA2432760A1 Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof |
| 06/27/2002 | CA2432036A1 Means for the diagnosis and therapy of ctcl |
| 06/27/2002 | CA2431966A1 Liquid yeast compositions |
| 06/27/2002 | CA2431891A1 Mutations in neuronal gene sodium-channel alpha 1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 06/27/2002 | CA2431446A1 High affinity antibodies |
| 06/27/2002 | CA2431139A1 Oxidoreductases |
| 06/27/2002 | CA2431108A1 Lactobacillus strain producing levan and its use in human or pet food products |
| 06/27/2002 | CA2430973A1 Multifunctional protease inhibitors and their use in treatment of disease |
| 06/27/2002 | CA2430918A1 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds |
| 06/27/2002 | CA2430754A1 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 06/27/2002 | CA2430475A1 Methods and cells for detecting modulators of rgs proteins |
| 06/26/2002 | EP1217077A2 Novel bioluminescent assays and bacterial strains useful therein |
| 06/26/2002 | EP1217069A2 Nucleotide sequences which code for the ilvE gene |
| 06/26/2002 | EP1217007A2 Serum paraoxonase |
| 06/26/2002 | EP1216305A1 Lactobacillus delbruckii strain and its use for screening plasmids |
| 06/26/2002 | EP1216304A1 Whole cell catalyst comprising a hydantoinase, a racemase and a carbamoylase |
| 06/26/2002 | EP1216303A1 Novel detoxified mutants of escherichia coli heat-labile enterotoxin |
| 06/26/2002 | EP1216302A2 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof |
| 06/26/2002 | EP1216259A1 SIGNAL SEQUENCES FOR THE PRODUCTION OF LEU-HIRUDINE VIA SECRETION BY i E. COLI /i IN A CULTURE MEDIUM |
| 06/26/2002 | EP0784518B1 Microbiological parts washer |
| 06/26/2002 | EP0464147B1 Matrix metalloproteinase inhibitor peptides |
| 06/26/2002 | CN1355850A Hyaluronidase from hirudinaria manillensis, isolation, purification and recombinant method of production |
| 06/26/2002 | CN1355849A Novel desensitized aspartokinase |
| 06/26/2002 | CN1355848A Gene encoding flavone synthase |
| 06/26/2002 | CN1355846A Method for down-regulating IL5 activity |
| 06/26/2002 | CN1355845A PrP-like gene |